D
DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
Price:
5 690
KRW
1.25%
Market Closed
Market Cap:
₩161.9B
Balance Sheet
Balance Sheet Decomposition
DongKoo Bio & Pharma Co Ltd
DongKoo Bio & Pharma Co Ltd
Balance Sheet Decomposition is not available for
DongKoo Bio & Pharma Co Ltd
DongKoo Bio & Pharma Co Ltd
Balance Sheet
DongKoo Bio & Pharma Co Ltd
DongKoo Bio & Pharma Co Ltd
Currency: KRW
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
1 517
|
1 797
|
337
|
4 891
|
9 885
|
4 731
|
10 341
|
4 881
|
19 557
|
12 514
|
15 713
|
25 372
|
|
| Cash Equivalents |
1 517
|
1 797
|
337
|
4 891
|
9 885
|
4 731
|
10 341
|
4 881
|
19 557
|
12 514
|
15 713
|
25 372
|
|
| Short-Term Investments |
0
|
2 933
|
744
|
33
|
1 103
|
16 963
|
22 325
|
24 626
|
12 399
|
22 271
|
5 745
|
10 871
|
|
| Total Receivables |
15 603
|
15 275
|
12 847
|
15 820
|
21 245
|
22 034
|
20 681
|
17 592
|
16 408
|
19 403
|
22 449
|
23 953
|
|
| Accounts Receivables |
14 679
|
12 917
|
11 132
|
15 536
|
20 953
|
21 719
|
20 415
|
17 436
|
15 758
|
18 507
|
20 164
|
19 910
|
|
| Other Receivables |
924
|
2 358
|
1 715
|
284
|
292
|
315
|
266
|
156
|
650
|
896
|
2 285
|
4 043
|
|
| Inventory |
16 672
|
11 585
|
10 731
|
10 660
|
12 146
|
14 931
|
17 599
|
24 971
|
24 964
|
31 428
|
42 606
|
45 962
|
|
| Other Current Assets |
1 733
|
1 447
|
192
|
780
|
139
|
148
|
956
|
283
|
504
|
1 801
|
1 852
|
1 083
|
|
| Total Current Assets |
35 525
|
33 036
|
24 851
|
32 184
|
44 517
|
58 806
|
71 901
|
72 353
|
73 832
|
87 417
|
88 365
|
107 242
|
|
| PP&E Net |
30 342
|
29 824
|
31 583
|
29 581
|
28 237
|
31 787
|
38 489
|
40 377
|
40 051
|
39 681
|
50 483
|
66 222
|
|
| PP&E Gross |
30 342
|
29 824
|
31 583
|
29 581
|
0
|
31 787
|
38 489
|
40 377
|
40 051
|
39 681
|
50 483
|
66 222
|
|
| Accumulated Depreciation |
12 550
|
13 651
|
14 211
|
14 990
|
0
|
17 336
|
19 591
|
23 231
|
26 562
|
29 139
|
33 982
|
39 298
|
|
| Intangible Assets |
902
|
668
|
1 285
|
1 002
|
975
|
1 758
|
2 001
|
2 081
|
3 048
|
9 010
|
10 903
|
13 172
|
|
| Note Receivable |
85
|
185
|
44
|
0
|
0
|
0
|
0
|
17
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
4 513
|
4 189
|
2 660
|
2 178
|
1 756
|
10 774
|
19 731
|
26 492
|
35 495
|
33 616
|
39 797
|
50 416
|
|
| Other Long-Term Assets |
1 073
|
928
|
348
|
364
|
108
|
1 154
|
603
|
3 034
|
2 361
|
2 335
|
1 554
|
7 009
|
|
| Total Assets |
72 440
N/A
|
68 831
-5%
|
60 772
-12%
|
65 311
+7%
|
75 593
+16%
|
104 279
+38%
|
132 725
+27%
|
144 353
+9%
|
154 786
+7%
|
172 059
+11%
|
191 103
+11%
|
244 061
+28%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
7 020
|
5 855
|
6 422
|
8 987
|
9 954
|
9 554
|
11 241
|
9 191
|
11 591
|
14 300
|
11 202
|
15 591
|
|
| Accrued Liabilities |
2 535
|
2 790
|
2 988
|
2 849
|
3 623
|
4 528
|
4 456
|
4 683
|
6 496
|
8 412
|
10 274
|
11 337
|
|
| Short-Term Debt |
0
|
0
|
16 290
|
18 232
|
12 050
|
10 056
|
14 883
|
18 000
|
18 070
|
33 000
|
40 500
|
74 001
|
|
| Current Portion of Long-Term Debt |
22 515
|
23 445
|
12 941
|
2 217
|
565
|
585
|
2 415
|
524
|
5 453
|
568
|
843
|
1 556
|
|
| Other Current Liabilities |
5 934
|
9 189
|
12 870
|
8 994
|
8 389
|
3 893
|
5 351
|
8 110
|
8 412
|
9 764
|
10 501
|
12 766
|
|
| Total Current Liabilities |
38 004
|
41 279
|
51 512
|
41 280
|
34 580
|
28 615
|
38 345
|
40 508
|
50 022
|
66 044
|
73 318
|
115 251
|
|
| Long-Term Debt |
15 437
|
7 995
|
5 950
|
1 248
|
2 412
|
1 925
|
5 499
|
5 219
|
770
|
754
|
2 461
|
11 084
|
|
| Deferred Income Tax |
41
|
0
|
0
|
739
|
785
|
445
|
2 967
|
3 034
|
2 315
|
141
|
4
|
9
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
45
|
116
|
|
| Other Liabilities |
316
|
354
|
760
|
0
|
72
|
1 196
|
262
|
940
|
1 555
|
3 015
|
4 874
|
12 269
|
|
| Total Liabilities |
53 798
N/A
|
49 629
-8%
|
58 221
+17%
|
43 266
-26%
|
37 849
-13%
|
32 181
-15%
|
47 073
+46%
|
49 701
+6%
|
54 662
+10%
|
69 953
+28%
|
80 703
+15%
|
138 729
+72%
|
|
| Equity | |||||||||||||
| Common Stock |
3 470
|
3 470
|
2 409
|
3 414
|
3 811
|
4 802
|
4 802
|
4 802
|
14 232
|
14 232
|
14 232
|
14 232
|
|
| Retained Earnings |
1 062
|
1 607
|
397
|
10 515
|
21 459
|
25 454
|
41 002
|
49 727
|
57 158
|
61 675
|
69 735
|
67 320
|
|
| Additional Paid In Capital |
8 363
|
8 363
|
1 534
|
8 887
|
13 153
|
42 569
|
42 569
|
42 569
|
33 063
|
33 063
|
33 063
|
33 063
|
|
| Unrealized Security Profit/Loss |
5 806
|
5 827
|
691
|
835
|
683
|
661
|
656
|
381
|
266
|
193
|
283
|
648
|
|
| Treasury Stock |
60
|
66
|
66
|
66
|
66
|
66
|
2 065
|
2 065
|
4 062
|
0
|
7 137
|
10 545
|
|
| Other Equity |
0
|
0
|
238
|
131
|
71
|
0
|
0
|
0
|
0
|
7 058
|
225
|
613
|
|
| Total Equity |
18 642
N/A
|
19 202
+3%
|
2 550
-87%
|
22 045
+765%
|
37 745
+71%
|
72 098
+91%
|
85 652
+19%
|
94 653
+11%
|
100 124
+6%
|
102 106
+2%
|
110 400
+8%
|
105 332
-5%
|
|
| Total Liabilities & Equity |
72 440
N/A
|
68 831
-5%
|
60 772
-12%
|
65 311
+7%
|
75 593
+16%
|
104 279
+38%
|
132 725
+27%
|
144 353
+9%
|
154 786
+7%
|
172 059
+11%
|
191 103
+11%
|
244 061
+28%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
14
|
14
|
14
|
20
|
23
|
29
|
28
|
28
|
28
|
28
|
28
|
28
|
|
| Preferred Shares Outstanding |
2
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
